CCP
TMO icon

Clough Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Clough Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,700
Closed -$936K – 184
2022
Q4 		$936K Buy
+1,700
New +$901K 0.09% 130
2022
Q2 		– Sell
-9,167
Closed -$5.41M – 121
2022
Q1 		$5.41M Sell
9,167
-6,450
-41% -$3.71M 0.41% 63
2021
Q4 		$10.4M Sell
15,617
-17,580
-53% -$11M 0.7% 45
2021
Q3 		$19M Sell
33,197
-8,890
-21% -$4.88M 1.15% 35
2021
Q2 		$21.2M Sell
42,087
-5,455
-11% -$2.57M 1.15% 31
2021
Q1 		$21.7M Sell
47,542
-8,610
-15% -$4.11M 0.97% 40
2020
Q4 		$26.2M Buy
56,152
+13,679
+32% +$6.41M 1.86% 16
2020
Q3 		$18.8M Buy
42,473
+5,090
+14% +$2.1M 1.35% 26
2020
Q2 		$13.5M Buy
37,383
+7,325
+24% +$2.46M 1.33% 23
2020
Q1 		$8.52M Sell
30,058
-18,760
-38% -$5.92M 0.85% 36
2019
Q4 		$15.9M Sell
48,818
-8,530
-15% -$2.59M 1.35% 26
2019
Q3 		$16.7M Buy
57,348
+21,158
+58% +$6.06M 1.38% 23
2019
Q2 		$10.6M Buy
+36,190
New +$9.97M 1.04% 35

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Clough Capital Partners's TMO Position: Q1 2023 in Review

Clough Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 1,700 shares — an estimated $936K sold.

Clough Capital Partners first reported a position in TMO in Q2 2019 and held it in 13 quarters. The position peaked at $26.2M in Q4 2020. 2,386 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Clough Capital Partners reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
  • Clough Capital Partners sold 1,700 Thermo Fisher Scientific shares in Q1 2023, an estimated $936K.
  • Clough Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2019 and held it in 13 quarters.
  • Clough Capital Partners's Thermo Fisher Scientific position peaked at $26.2M in Q4 2020.
  • 2,386 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Clough Capital Partners's 13F filing for Q1 2023, filed 15 May 2023.